Suchergebnisse - "Murray, Daniel D"

PubPharm (42)

1

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

enthalten in: The Journal of infectious diseases | 2024

von Jensen, T. | Grandits, G. | Jain, M. | +131

2

SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracing

enthalten in: The Journal of infection | 2024

von Murray, J. | Murray, D. | Schvoerer, E. | +1

3

Central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome: a cross-sectional cohort study

enthalten in: bioRxiv.org | 2023

von Gelpi, M. | Mikaeloff, F. | Dehlbæk Knudsen, A. | +7

4

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO) : a randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Brown, S. | Barkauskas, C. | Grund, B. | +185

CommentIn: Lancet Respir Med. 2023 Sep;11(9):759-760. - PMID 37348523

5

Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort

enthalten in: AIDS (London, England) | 2023

von Zucco, A. | Bennedbæk, M. | Ekenberg, C. | +8

CommentIn: AIDS. 2023 Sep 1;37(11):1757-1758. - PMID 37534725

6

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection

enthalten in: Metabolites | 2023

von Rasmussen, K. | Dos Santos, Q. | MacPherson, C. | +10

7

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection

enthalten in: NEJM evidence | 2023

von Lundgren, J. | Babiker, A. | Sharma, S. | +69

8

Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

enthalten in: AIDS (London, England) | 2023

von Murray, D. | Grund, B. | MacPherson, C. | +13

9

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

10

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

enthalten in: International journal of molecular sciences | 2022

von Jørgensen, M. | Nørgaard, J. | Ilett, E. | +7

1
2
3
4
5
Nächster »
[5]